GlassScriptPhysician profile
Joseph C Liu
NPI 1750382362
$21,567.42
in general payments reported to CMS, 2019-2025
40 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $389 · 2021: $520 · 2022: $707 · 2023: $902 · 2024: $1,132 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,812.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,385.51 | 2019 | |
| Lilly USA, LLC | $6,030.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $979.00 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $701.98 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $701.13 | 2019-2025 | |
| Abbott Laboratories | $581.57 | 2019-2023 | Optis, Ensite |
| Amgen INC. | $493.49 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $480.94 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, Bodyguardian |
| Pfizer INC. | $270.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $225.17 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $211.41 | 2019-2024 | |
| Atricure, INC. | $195.87 | 2023-2024 | |
| Lantheus Medical Imaging, INC. | $147.81 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $133.60 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Inspire Medical Systems, INC. | $117.74 | 2024-2025 | Inspire |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $103.29 | 2023-2025 | Guideliner, Vascband |
| Baxter Healthcare | $85.19 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $61.72 | 2019 | |
| Novo Nordisk INC | $57.35 | 2022-2023 | Rybelsus, Ozempic |
| Abiomed | $55.91 | 2023 | Impella |
| Philips North America LLC | $51.26 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $49.89 | 2019-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $48.31 | 2019-2022 | |
| Shockwave Medical, INC | $46.74 | 2025 | |
| Gilead Sciences, INC. | $38.83 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $34.25 | 2019 | |
| Esperion Therapeutics, INC. | $33.81 | 2021-2024 | Nexletol |
| Astellas Pharma US INC | $32.72 | 2019 | |
| Heartflow, INC. | $23.90 | 2025 | |
| Biosense Webster, INC. | $20.73 | 2023 | |
| Vital Connect, INC | $20.38 | 2024 | Vitalpatch Rtm |
| Stryker Corporation | $19.87 | 2024 | Axsos |
| Alnylam Pharmaceuticals INC. | $18.36 | 2023 | Amvuttra |
| Merck Sharp & Dohme LLC | $18.12 | 2023 | Verquvo |
| Inogen, INC. | $17.36 | 2022 | |
| Edwards Lifesciences Corporation | $16.55 | 2025 | |
| Genzyme Corporation | $15.71 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2023 | |
| Irhythm Technologies, INC. | $12.88 | 2020 | |
| Altathera Pharmaceuticals LLC | $12.51 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.